Patients with T2DM display increased IL-1β levels (Boni-Schnetzler et al., 2008), while its naturally occurring IL-1 receptor antagonist (IL-1Ra) is diminished (Maedler et al., 2004). This evidence concerns the gene IL1B and type 2 diabetes mellitus.